RE:RE:Market SlaughterThis Phase III company has been severely undervalued for years. When approval arrives ( for whatever indication because it won't really matter, off label will be big), it will overshoot real value, a natural occurance ( law of averages ).Whatever value it will be is anyones guess. A little North of $6 would be my guess.JMHO
Another reason for this is it will be a media darling and get news coverage. After all ,some people think that no sub $400 million market cap co. ( or whatever it is ) has never gotten FDA approval. People will be looking for a stock that is going up in this ravaged market, and is only going to get worse during the year.
I haven't even mentioned the real value in MCNA / Oncocidin being an adjuvant to chemo in bringing the white blood cells to balance after 24-48 hours. This is where the real future value to MCNA is.https://www.telestatherapeutics.com/cms/phpmlj3QG.pdf
Cheers
13PD